Crossmark Global Holdings’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,645
Closed -$237K 1357
2023
Q4
$237K Sell
3,645
-343
-9% -$20.7K ﹤0.01% 1186
2023
Q3
$269K Sell
3,988
-166
-4% -$10.4K 0.01% 1071
2023
Q2
$241K Sell
4,154
-55
-1% -$3.47K 0.01% 1163
2023
Q1
$260K Buy
4,209
+160
+4% +$9.6K 0.01% 1103
2022
Q4
$257K Buy
4,049
+229
+6% +$16.6K 0.01% 1085
2022
Q3
$277K Buy
+3,820
New +$284K 0.01% 1031

Other funds holding NARI

Crossmark Global Holdings's NARI Position: Q1 2024 in Review

Crossmark Global Holdings sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 3,645 shares — an estimated $237K sold.

Crossmark Global Holdings first reported a position in NARI in Q3 2022 and held it in 6 quarters. The position peaked at $277K in Q3 2022. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Crossmark Global Holdings reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 3,645 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $237K.
  • Crossmark Global Holdings first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Crossmark Global Holdings's Inari Medical, Inc. Common Stock position peaked at $277K in Q3 2022.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Crossmark Global Holdings's 13F filing for Q1 2024, filed 13 May 2024.